E Fund Management Co., Ltd. Halozyme Therapeutics, Inc. Transaction History
E Fund Management Co., Ltd.
- $1.6 Billion
- Q1 2024
A detailed history of E Fund Management Co., Ltd. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 10,385 shares of HALO stock, worth $535,450. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,385
Previous 12,023
13.62%
Holding current value
$535,450
Previous $444,000
4.95%
% of portfolio
0.03%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding HALO
# of Institutions
442Shares Held
122MCall Options Held
216KPut Options Held
140K-
Black Rock Inc. New York, NY18.2MShares$941 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$673 Million0.01% of portfolio
-
State Street Corp Boston, MA6.49MShares$334 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.12MShares$212 Million3.73% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.79MShares$195 Million0.24% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.18B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...